390 related articles for article (PubMed ID: 32973449)
41. The Role of MicroRNAs in Aβ Deposition and Tau Phosphorylation in Alzheimer's Disease.
Zhao J; Yue D; Zhou Y; Jia L; Wang H; Guo M; Xu H; Chen C; Zhang J; Xu L
Front Neurol; 2017; 8():342. PubMed ID: 28769871
[TBL] [Abstract][Full Text] [Related]
42. The Regulation of microRNAs in Alzheimer's Disease.
Kou X; Chen D; Chen N
Front Neurol; 2020; 11():288. PubMed ID: 32362867
[TBL] [Abstract][Full Text] [Related]
43. Cost-effectiveness of the use of biomarkers in cerebrospinal fluid for Alzheimer's disease.
Valcárcel-Nazco C; Perestelo-Pérez L; Molinuevo JL; Mar J; Castilla I; Serrano-Aguilar P
J Alzheimers Dis; 2014; 42(3):777-88. PubMed ID: 24916543
[TBL] [Abstract][Full Text] [Related]
44. Identification of age- and disease-related alterations in circulating miRNAs in a mouse model of Alzheimer's disease.
Garza-Manero S; Arias C; Bermúdez-Rattoni F; Vaca L; Zepeda A
Front Cell Neurosci; 2015; 9():53. PubMed ID: 25745387
[TBL] [Abstract][Full Text] [Related]
45. Cerebrospinal Fluid Biomarkers for Early and Differential Alzheimer's Disease Diagnosis.
Bjerke M; Engelborghs S
J Alzheimers Dis; 2018; 62(3):1199-1209. PubMed ID: 29562530
[TBL] [Abstract][Full Text] [Related]
46. Brain-related proteins as potential CSF biomarkers of Alzheimer's disease: A targeted mass spectrometry approach.
Begcevic I; Brinc D; Brown M; Martinez-Morillo E; Goldhardt O; Grimmer T; Magdolen V; Batruch I; Diamandis EP
J Proteomics; 2018 Jun; 182():12-20. PubMed ID: 29684683
[TBL] [Abstract][Full Text] [Related]
47. Critical Comparison of Different Biomarkers for Alzheimer's Disease in a Clinical Setting.
Weise D; Tiepolt S; Awissus C; Hoffmann KT; Lobsien D; Kaiser T; Barthel H; Sabri O; Gertz HJ
J Alzheimers Dis; 2015; 48(2):425-32. PubMed ID: 26402006
[TBL] [Abstract][Full Text] [Related]
48. Circulating microRNAs as novel biomarkers of Alzheimer's disease.
Zendjabil M
Clin Chim Acta; 2018 Sep; 484():99-104. PubMed ID: 29800558
[TBL] [Abstract][Full Text] [Related]
49. miRNA expression profiles in cerebrospinal fluid and blood of patients with Alzheimer's disease and other types of dementia - an exploratory study.
Sørensen SS; Nygaard AB; Christensen T
Transl Neurodegener; 2016; 5():6. PubMed ID: 26981236
[TBL] [Abstract][Full Text] [Related]
50. MicroRNAs in Alzheimer's disease.
Delay C; Mandemakers W; Hébert SS
Neurobiol Dis; 2012 May; 46(2):285-90. PubMed ID: 22285895
[TBL] [Abstract][Full Text] [Related]
51. The emerging role of microRNAs in Alzheimer's disease.
Femminella GD; Ferrara N; Rengo G
Front Physiol; 2015; 6():40. PubMed ID: 25729367
[TBL] [Abstract][Full Text] [Related]
52. The Serum Exosome Derived MicroRNA-135a, -193b, and -384 Were Potential Alzheimer's Disease Biomarkers.
Yang TT; Liu CG; Gao SC; Zhang Y; Wang PC
Biomed Environ Sci; 2018 Feb; 31(2):87-96. PubMed ID: 29606187
[TBL] [Abstract][Full Text] [Related]
53. Are microRNAs the Molecular Link Between Metabolic Syndrome and Alzheimer's Disease?
Codocedo JF; Ríos JA; Godoy JA; Inestrosa NC
Mol Neurobiol; 2016 May; 53(4):2320-38. PubMed ID: 25976367
[TBL] [Abstract][Full Text] [Related]
54. Circulating miRNAs as potential biomarkers in Alzheimer's disease.
Galimberti D; Villa C; Fenoglio C; Serpente M; Ghezzi L; Cioffi SM; Arighi A; Fumagalli G; Scarpini E
J Alzheimers Dis; 2014; 42(4):1261-7. PubMed ID: 25024331
[TBL] [Abstract][Full Text] [Related]
55. Machine Learning to Detect Alzheimer's Disease from Circulating Non-coding RNAs.
Ludwig N; Fehlmann T; Kern F; Gogol M; Maetzler W; Deutscher S; Gurlit S; Schulte C; von Thaler AK; Deuschle C; Metzger F; Berg D; Suenkel U; Keller V; Backes C; Lenhof HP; Meese E; Keller A
Genomics Proteomics Bioinformatics; 2019 Aug; 17(4):430-440. PubMed ID: 31809862
[TBL] [Abstract][Full Text] [Related]
56. Genetic markers for diagnosis and pathogenesis of Alzheimer's disease.
Kim DH; Yeo SH; Park JM; Choi JY; Lee TH; Park SY; Ock MS; Eo J; Kim HS; Cha HJ
Gene; 2014 Jul; 545(2):185-93. PubMed ID: 24838203
[TBL] [Abstract][Full Text] [Related]
57. APP processing and metabolism in corneal fibroblasts and epithelium as a potential biomarker for Alzheimer's disease.
Choi SI; Lee B; Woo JH; Jeong JB; Jun I; Kim EK
Exp Eye Res; 2019 May; 182():167-174. PubMed ID: 30930125
[TBL] [Abstract][Full Text] [Related]
58. MicroRNA (miRNA)-Mediated Pathogenetic Signaling in Alzheimer's Disease (AD).
Hill JM; Lukiw WJ
Neurochem Res; 2016 Feb; 41(1-2):96-100. PubMed ID: 26441222
[TBL] [Abstract][Full Text] [Related]
59. Noncoding RNAs in Alzheimer's disease.
Idda ML; Munk R; Abdelmohsen K; Gorospe M
Wiley Interdiscip Rev RNA; 2018 Mar; 9(2):. PubMed ID: 29327503
[TBL] [Abstract][Full Text] [Related]
60. MicroRNAs as diagnostic and therapeutic tools for Alzheimer's disease: advances and limitations.
Martinez B; Peplow PV
Neural Regen Res; 2019 Feb; 14(2):242-255. PubMed ID: 30531004
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
